1
|
Xie S, Yu Y, Liu Y, Zhang S, Yuan S, Fan K, Tang B, Zhou Q, Sun Y, Liu R, Cao D, Chen Y, Wang Y, Liu G, Ma H, Tao C, Zeng L, Zhong L. Effectiveness and Safety of Ultrasound-Guided Local Paricalcitol Injection in Treating Secondary Hyperparathyroidism in ESRD: A Retrospective Study. J Clin Med 2022; 11:jcm11226860. [PMID: 36431337 PMCID: PMC9693598 DOI: 10.3390/jcm11226860] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2022] [Revised: 11/16/2022] [Accepted: 11/19/2022] [Indexed: 11/22/2022] Open
Abstract
PURPOSE To compare the safety and efficacy of percutaneous paricalcitol injection with intravenously administered paricalcitol in treating parathyroid hyperplasia in patients with secondary hyperparathyroidism (SHPT). METHODS This study was approved by the Ethics Committee of our institution. We retrospectively collected data on patients who received percutaneous paricalcitol injection (24 patients) and intravenously administered paricalcitol (22 patients) based on their intact parathyroid hormone (iPTH) level. Serum iPTH, calcium, phosphorus, and the volume of the parathyroid gland were measured at several indicated time points after treatment, and adverse events associated with the two treatments were evaluated. RESULTS After 6 months of follow-up, we found that patients from the percutaneous injection group had significantly decreased levels of iPTH (from 1887.81 ± 726.81 pg/mL to 631.06 ± 393.06 pg/mL), phosphate (from 1.94 ± 0.36 mmol/L to 1.71 ± 0.34 mmol/L), and volume of the parathyroid gland (from 0.87 ± 0.50 cm3 to 0.60 ± 0.36 cm3), with relief from ostealgia within 48-72 h. In the intravenously administered group, the levels of iPTH decreased from 686.87 ± 260.44 pg/mL to 388.47 ± 167.36 pg/mL; while there was no significant change in phosphate levels, the volume of the parathyroid gland and ostealgia relief were observed at the end of follow-up. The serum calcium level did not significantly change, and no severe complications were observed in both groups. In vitro fluorescence-activated single cell sorting (FACS) analysis indicated that paricalcitol induced parathyroid cell apoptosis in a dose-dependent manner. CONCLUSIONS Percutaneous paricalcitol injection is a selective treatment for SHPT in ESRD.
Collapse
Affiliation(s)
- Shuqin Xie
- Department of Nephrology, Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China
| | - Yuan Yu
- Department of Nephrology, Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China
| | - Yi Liu
- Department of Nephrology, Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China
| | - Siliang Zhang
- Department of Nephrology, Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China
| | - Shiyi Yuan
- Department of Nephrology, Yongchuan People’s Hospital of Chongqing, Chongqing 402160, China
| | - Kui Fan
- Department of Nephrology, Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China
| | - Bin Tang
- Department of Nephrology, Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China
| | - Qin Zhou
- Department of Nephrology, Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China
| | - Yuqing Sun
- Department of Nephrology, Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China
| | - Rui Liu
- Department of Nephrology, Dianjiang People’s Hospital of Chongqing, Chongqing 408300, China
| | - Dan Cao
- The Department of Nephrology, The Fifth Hospital of Chongqing, Chongqing 400062, China
| | - Yong Chen
- Department of Nephrology and Hematopathology, Second Affiliated Hospital at Fengjie, Chongqing Medical University, Chongqing 404600, China
| | - Yelei Wang
- Department of Nephrology, People’s Hospital of Pengshui County, Chongqing 409600, China
| | - Guangjun Liu
- Department of Nephrology, People’s Hospital of Shizhu County, Chongqing 409100, China
| | - Huan Ma
- Department of Nephrology, Dianjiang People’s Hospital of Chongqing, Chongqing 408300, China
| | - Chenghui Tao
- Department of Nephrology, Fengdu People’s Hospital, Chongqing 408200, China
| | - Li Zeng
- Department of Nephrology, Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China
- Correspondence: (L.Z.); (L.Z.)
| | - Ling Zhong
- Department of Nephrology, Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China
- Correspondence: (L.Z.); (L.Z.)
| |
Collapse
|